Zhang Y, Zhu W, Tao R, Li W, Jiang C, Yan X
J Transl Med. 2025; 23(1):116.
PMID: 39863860
PMC: 11763126.
DOI: 10.1186/s12967-025-06091-4.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y
J Pharm Anal. 2024; 14(7):100947.
PMID: 39149142
PMC: 11325817.
DOI: 10.1016/j.jpha.2024.02.001.
Xu Y, Gao Z, Sun X, Li J, Ozaki T, Shi D
Cancer Metastasis Rev. 2024; 43(3):1055-1074.
PMID: 38558156
DOI: 10.1007/s10555-024-10182-x.
Turgambayeva A, Duisekova S, Tashenova G, Tulebayeva A, Kapanova G, Akhenbekova A
Noncoding RNA Res. 2024; 9(2):359-366.
PMID: 38511066
PMC: 10950581.
DOI: 10.1016/j.ncrna.2023.12.001.
Alhammadi M, Bajbouj K, Talaat I, Hamoudi R
Cell Death Dis. 2024; 15(3):227.
PMID: 38503745
PMC: 10951318.
DOI: 10.1038/s41419-024-06479-y.
Regulation of Angiogenesis by Non-Coding RNAs in Cancer.
Su Z, Li W, Lei Z, Hu L, Wang S, Guo L
Biomolecules. 2024; 14(1).
PMID: 38254660
PMC: 10813527.
DOI: 10.3390/biom14010060.
Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective.
Huang C, Esfani Sarafraz P, Enayati P, Mortazavi Mamaghani E, Babakhanzadeh E, Nazari M
Cancer Cell Int. 2023; 23(1):288.
PMID: 37993909
PMC: 10664289.
DOI: 10.1186/s12935-023-03128-w.
Identification of circATG9A as a novel biomarker for renal cell carcinoma.
Shen Y, Wu R, Zhuo Z, Deng X, Li W, Liu C
Cancer Gene Ther. 2023; 31(1):82-93.
PMID: 37945969
DOI: 10.1038/s41417-023-00684-1.
Characterization of the TRPV6 calcium channel-specific phenotype by RNA-seq in castration-resistant human prostate cancer cells.
Cordier C, Haustrate A, Prevarskaya N, Lehenkyi V
Front Genet. 2023; 14:1215645.
PMID: 37576552
PMC: 10415680.
DOI: 10.3389/fgene.2023.1215645.
Development and verification of a deep learning-based mA modification model for clinical prognosis prediction of renal cell carcinoma.
Chen S, Zhang E, Guo T, Wang T, Chen J, Zhang N
J Cancer Res Clin Oncol. 2023; 149(15):14283-14296.
PMID: 37558767
DOI: 10.1007/s00432-023-05169-0.
Study of MicroRNA Cluster Located on Chromosome X in Serum and Breast Cancer Tissue.
Rasool A, Haghi M, Feizi M
Biochem Genet. 2023; 62(2):1115-1135.
PMID: 37544000
DOI: 10.1007/s10528-023-10448-z.
CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling.
Wu D, Li Y, Xu A, Tang W, Yu B
Cancers (Basel). 2023; 15(7).
PMID: 37046729
PMC: 10093195.
DOI: 10.3390/cancers15072068.
The function and mechanisms of action of circular RNAs in Urologic Cancer.
Zhang Z, Wang Y, Zhang Y, Zheng S, Feng T, Tian X
Mol Cancer. 2023; 22(1):61.
PMID: 36966306
PMC: 10039696.
DOI: 10.1186/s12943-023-01766-2.
Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma.
Liu A, Li F, Wang B, Yang L, Xing H, Su C
Front Pharmacol. 2023; 13:1055841.
PMID: 36588677
PMC: 9795407.
DOI: 10.3389/fphar.2022.1055841.
circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p.
Zhao B, Huang C, Pan J, Hu H, Liu X, Zhang K
Cell Death Dis. 2022; 13(12):1030.
PMID: 36494341
PMC: 9734136.
DOI: 10.1038/s41419-022-05488-z.
Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.
Cui C, Zhang Y, Liu G, Zhang S, Zhang J, Wang X
Explor Target Antitumor Ther. 2022; 2(3):266-291.
PMID: 36046433
PMC: 9400724.
DOI: 10.37349/etat.2021.00046.
Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
Rashedi S, Mardani M, Rafati A, Khavandi M, Mohammadi F, Javanshir S
J Clin Lab Anal. 2022; 36(10):e24670.
PMID: 35989533
PMC: 9550963.
DOI: 10.1002/jcla.24670.
Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma.
Mao W, Wang K, Zhang W, Chen S, Xie J, Zheng Z
J Exp Clin Cancer Res. 2022; 41(1):252.
PMID: 35986402
PMC: 9389749.
DOI: 10.1186/s13046-022-02467-2.
Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.
Xu Z, Chen S, Liu R, Chen H, Xu B, Xu W
Mol Cancer. 2022; 21(1):146.
PMID: 35840930
PMC: 9284792.
DOI: 10.1186/s12943-022-01607-8.
Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.
Osca-Verdegal R, Beltran-Garcia J, Gorriz J, Jabaloyas J, Pallardo F, Garcia-Gimenez J
Front Cell Dev Biol. 2022; 10:879814.
PMID: 35813211
PMC: 9257016.
DOI: 10.3389/fcell.2022.879814.